Item 1.01 Entry into Material Definitive Agreement.

On January 15, 2009, Colloral LLC, AutoImmune's joint venture with Deseret Laboratories, Inc., and Futurebiotics, LLC entered into a Second Amendment to Supply and License Agreement (the "Amendment"). The Amendment amends the Supply and License Agreement between Colloral LLC and Futurebiotics, LLC dated effective as of January 10, 2007, as amended (the "Supply Agreement").

The Amendment extends the initial term of exclusivity that Colloral LLC has granted to Futurebiotics LLC under the Supply Agreement until June 30, 2010, and extends the period during which Futurebiotics, LLC may extend its exclusivity under certain conditions. Futurebiotics, LLC has committed to spend minimum amounts on direct-response marketing during the term of the Amendment.

This description of the Amendment is qualified in its entirety by reference to the Amendment, which AutoImmune intends to file as an exhibit to its Quarterly Report on Form 10-Q for the quarterly period ending March 30, 2009. When AutoImmune files the Amendment as an exhibit to its Quarterly Report on Form 10-Q, it intends to request confidential treatment with respect to certain terms of the Amendment.

---